---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-010747"
form_type: "8-K"
ticker: null
cik: "0000876378"
company_name: "ASENSUS SURGICAL, INC."
filed_at: "2024-04-03T23:59:59+00:00"
generated_at: "2026-06-04T03:11:13.531608+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Asensus Surgical receives non-binding acquisition proposal from KARL STORZ at $0.35/share, plus $20M bridge loan

## Summary
- KARL STORZ proposes to acquire all shares for $0.35/share cash, representing 66.7% premium to April 2 close.
- Exclusive negotiations for up to 10 weeks; KARL STORZ provides up to $20M secured bridge loan to fund operations.
- Bridge loan provides up to $10M during exclusivity period, additional $10M after definitive merger agreement signed.
- No assurance deal will close; requires due diligence, definitive agreement, Board and stockholder approval.
- Bridge loan has SOFR+10% interest rate, secured by all company assets including intellectual property.

## SEC filing metadata
- accession: 0001437749-24-010747
- form_type: 8-K
- cik: 0000876378
- company_name: ASENSUS SURGICAL, INC.
- filed_at: 2024-04-03T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 2.03, 3.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/876378/000143774924010747/0001437749-24-010747-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/876378/000143774924010747/asxc20240402_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-010747
- JSON: https://secwatch.observer/filing/0001437749-24-010747.json
- Plain text: https://secwatch.observer/filing/0001437749-24-010747.txt

## Key facts
- Debt Financings
  ASENSUS SURGICAL, INC. incurred loan of up to $20 million with KARL STORZ SE & Co. KG at SOFR plus 10% maturing the earliest of (i) the date that is thirty days after the Company ceases discussions... (ii) the date that is sixty days after the lapse of the Exclusivity Per.
  - Instrument: loan
  - Principal: up to $20 million
  - Counterparty: KARL STORZ SE & Co. KG
  - Rate: SOFR plus 10%
  - Maturity: the earliest of (i) the date that is thirty days after the Company ceases discussions... (ii) the date that is sixty days after the lapse of the Exclusivity Per
  - Event: incurrence
  source text: On April 3, 2024, Asensus Surgical, Inc. (the "Company") issued a promissory note in favor of KARL STORZ SE & Co. KG ("KARL STORZ") in the principal amount of up to $20 million (the "Note").
  evidence_url: https://www.sec.gov/Archives/edgar/data/876378/000143774924010747/0001437749-24-010747-index.htm
- Material Agreements
  ASENSUS SURGICAL, INC. entered into Note with KARL STORZ SE & Co. KG valued at up to $20 million (effective 2024-04-03).
  - Action: entry
  - Agreement: credit facility
  - Counterparty: KARL STORZ SE & Co. KG
  - Value: up to $20 million
  - Effective: 2024-04-03
  source text: On April 3, 2024, Asensus Surgical, Inc. (the “Company”) issued a promissory note in favor of KARL STORZ SE & Co. KG (“KARL STORZ”) in the principal amount of up to $20 million (the “Note”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/876378/000143774924010747/0001437749-24-010747-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.